SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-207867
Filing Date
2022-08-01
Accepted
2022-08-01 09:17:06
Documents
16
Period of Report
2022-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d346512d8k.htm   iXBRL 8-K 28588
2 EX-3.1 d346512dex31.htm EX-3.1 4917
3 EX-3.2 d346512dex32.htm EX-3.2 150585
4 EX-99.1 d346512dex991.htm EX-99.1 30120
8 GRAPHIC g346512g0801081805238.jpg GRAPHIC 5340
  Complete submission text file 0001193125-22-207867.txt   393845

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crtx-20220801.xsd EX-101.SCH 2527
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20220801_lab.xml EX-101.LAB 19746
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20220801_pre.xml EX-101.PRE 12295
10 EXTRACTED XBRL INSTANCE DOCUMENT d346512d8k_htm.xml XML 3885
Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 221123037
SIC: 2836 Biological Products, (No Diagnostic Substances)